PSI-352938

DB12896InvestigationalSmall molecule

PSI-352938 has been used in trials studying the treatment of Hepatitis C and Hepatitis C, Chronic.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₁₆H₂₃FN₅O₆P · 431.361 g/mol (avg)
Code names: PSI-352938

Resolves to

Compound

Structure

InChIKeyPVRFQJIRERYGTQ-DSQUMVBZSA-NSMILESCCOC1=C2N=CN([C@@H]3O[C@@H]4CO[P@@](=O)(OC(C)C)O[C@H]4[C@@]3(C)F)C2=NC(N)=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with PSI-352938, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.